The FDA's draft guidance clarifying its requirements on medical device recalls has elicited concerns from the industry. "[W]e believe significant aspects of the Draft Guidance are at odds with existing FDA regulation and policy, and that it is necessary to resolve these discrepancies prior to issuing guidance or regulation in this area," AdvaMed said. Boston Scientific echoed AdvaMed's concerns, saying the guidance "has not achieved its purpose in clarifying the difference between product enhancements and recalls."
FDA proposal on device recalls draws industry concerns
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan